Skin toxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective pharmacovigilance study using FAERS

Background Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) are widely used in solid tumor therapy, accompanied by a high rate of dermatologic adverse events that severely disrupt treatment. However, their real-world characteristics and drug-specific differences remain unclear. Objective To analyze the characteristics of skin adverse events associated with 11 VEGFR-TKIs in the real world using the FDA Adverse Event Reporting System (FAERS) database, providing evidence for clinical safety management. Methods FAERS data from 2004 to 2025 were included. Signal detection was conducted using the ROR, PRR, IC, and EBGM, combined with demographic analysis, time to onset, and Weibull modeling. Results A total of 34,088 cases of skin adverse events were included, with hand-foot skin reaction (HFSR) being the most common signal. Sorafenib, cabozantinib, and vandetanib exhibited more pronounced toxicity signals. Some drugs presented specific manifestations: sunitinib with skin yellowing, pazopanib with hair color changes, and cabozantinib with skin ulceration. Most skin-related adverse events occurred early during treatment (within 4 weeks). Conclusion VEGFR-TKIs demonstrate both common and specific skin toxicities, which predominantly occur early and are associated with efficacy, providing real-world evidence to support individualized clinical monitoring and early interventions.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.2019073
Primary Topic
Chemotherapy-related skin toxicity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Skin toxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective pharmacovigilance study using FAERS

Bozhou Wang, Qijin Shu, Jinsheng Yu, Yi Liu et al.
1 links
Frontiers in Pharmacology
Chemotherapy-related skin toxicity
article

Skin toxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective pharmacovigilance study using FAERS

Bozhou Wang, Qijin Shu, Jinsheng Yu, Yi Liu, Fangmin Zhao, Mujia Shi, Jinhan Chen, Xu Qian, Huiwen Sun
article en

Abstract

Background Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) are widely used in solid tumor therapy, accompanied by a high rate of dermatologic adverse events that severely disrupt treatment. However, their real-world characteristics and drug-specific differences remain unclear. Objective To analyze the characteristics of skin adverse events associated with 11 VEGFR-TKIs in the real world using the FDA Adverse Event Reporting System (FAERS) database, providing evidence for clinical safety management. Methods FAERS data from 2004 to 2025 were included. Signal detection was conducted using the ROR, PRR, IC, and EBGM, combined with demographic analysis, time to onset, and Weibull modeling. Results A total of 34,088 cases of skin adverse events were included, with hand-foot skin reaction (HFSR) being the most common signal. Sorafenib, cabozantinib, and vandetanib exhibited more pronounced toxicity signals. Some drugs presented specific manifestations: sunitinib with skin yellowing, pazopanib with hair color changes, and cabozantinib with skin ulceration. Most skin-related adverse events occurred early during treatment (within 4 weeks). Conclusion VEGFR-TKIs demonstrate both common and specific skin toxicities, which predominantly occur early and are associated with efficacy, providing real-world evidence to support individualized clinical monitoring and early interventions.

Frontiers in PharmacologyVol. 17
Zhejiang Chinese Medical University (CN), Zhejiang Provincial Hospital of TCM (CN)
Good health and well-being
Chemotherapy-related skin toxicity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon